First Time Loading...
T

Thorne Healthtech Inc
NASDAQ:THRN

Watchlist Manager
Thorne Healthtech Inc
NASDAQ:THRN
Watchlist
Price: 10.19 USD Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

THRN Price Targets Summary
Thorne Healthtech Inc

Wall Street analysts forecast THRN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for THRN is 7 USD .

THRN Lowest Forecast
Wall Street Target
Not Available
THRN Average Forecast
Wall Street Target
7 USD
31% Downside
THRN Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
7 USD
31% Downside
Highest
Price Target
Not Available
Thorne Healthtech Inc Competitors:
Price Targets
L
LFMD
LifeMD Inc
4% Upside
USNA
USANA Health Sciences Inc
33% Upside
G
603983
Guangdong Marubi Biotechnology Co Ltd
8% Upside
003006
Chongqing Baiya Sanitory Products Co Ltd
1% Upside
L
LFMD
LifeMD Inc
4% Upside
USNA
USANA Health Sciences Inc
33% Upside
G
603983
Guangdong Marubi Biotechnology Co Ltd
8% Upside
003006
Chongqing Baiya Sanitory Products Co Ltd
1% Upside
4190
Jourdeness Group Ltd
172% Upside
VERU
Veru Inc
121% Upside
Y
YSG
Yatsen Holding Ltd
5% Downside
SIS
Science in Sport PLC
94% Upside

Revenue
Forecast

Revenue Estimate
Thorne Healthtech Inc

For the last 2 years the compound annual growth rate for Thorne Healthtech Inc's revenue is 29%. The projected CAGR for the next 3 years is 23%.

29%
Past Growth
23%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Thorne Healthtech Inc

For the last 2 years the compound annual growth rate for Thorne Healthtech Inc's operating income is 132%. The projected CAGR for the next 3 years is 130%.

132%
Past Growth
130%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Thorne Healthtech Inc

The compound annual growth rate of Thorne Healthtech Inc's net income for the next 3 years is 55%.

N/A
Past Growth
55%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
THRN intrinsic value, competitors valuation, and company profile.
DCF Valuation
THRN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
THRN stock valuation using valuation multiples.
Wall Street Estimates
THRN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
THRN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is THRN's stock price target?
Price Target
7 USD

According to Wall Street analysts, the average 1-year price target for THRN is 7 USD .

What is Thorne Healthtech Inc's Revenue forecast?
Projected CAGR
23%

For the last 2 years the compound annual growth rate for Thorne Healthtech Inc's revenue is 29%. The projected CAGR for the next 3 years is 23%.

What is Thorne Healthtech Inc's Operating Income forecast?
Projected CAGR
130%

For the last 2 years the compound annual growth rate for Thorne Healthtech Inc's operating income is 132%. The projected CAGR for the next 3 years is 130%.

What is Thorne Healthtech Inc's Net Income forecast?
Projected CAGR
55%

The compound annual growth rate of Thorne Healthtech Inc's net income for the next 3 years is 55%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.